{"id":53241,"date":"2023-01-24T17:02:25","date_gmt":"2023-01-24T16:02:25","guid":{"rendered":"https:\/\/pharma-trend.com\/en\/heritage-group-expands-investment-team-and-announces-vice-president-promotion\/"},"modified":"2023-01-24T17:02:25","modified_gmt":"2023-01-24T16:02:25","slug":"heritage-group-expands-investment-team-and-announces-vice-president-promotion","status":"publish","type":"post","link":"https:\/\/pharma-trend.com\/en\/heritage-group-expands-investment-team-and-announces-vice-president-promotion\/","title":{"rendered":"Heritage Group Expands Investment Team and Announces Vice President Promotion"},"content":{"rendered":"
\n

NASHVILLE, Tenn.–(BUSINESS WIRE)–Heritage Group, a healthcare-focused private equity firm, is pleased to announce the promotion of Matt Tome to Vice President, as well as the addition of two new members to the investment team, Kevin Ryan, Vice President and Franklin Garstin, Associate.\n<\/p>\n

<\/a><\/p>\n

\nMatt Tome joined Heritage in 2019 as an Associate. Prior to joining Heritage, Matt was an Associate in the Debt Capital Markets group at Stephens Inc., where he worked on a range of leveraged finance transactions. Prior to working in debt capital markets, Matt was an analyst at Stephens working on mergers and acquisitions and capital raising transactions across a broad range of industries.\n<\/p>\n

\n\u201cWe are incredibly excited to announce Matt\u2019s well-deserved promotion to Vice President. Matt has made meaningful contributions to the firm and created value across all aspects of the investment process, from thematic investment work to post-closing portfolio company value creation,\u201d said Lauren Brueggen, Partner at Heritage Group.\n<\/p>\n

\n\u201cIn addition to his acumen as an investor, Matt is a wonderful steward of the firm\u2019s culture, and we are pleased to acknowledge these accomplishments through this promotion,\u201d said Rock Morphis and David McClellan, Founders of Heritage Group.\n<\/p>\n

\nHeritage is also excited to announce the expansion of its investment team with two recent additions to the team, which include Kevin Ryan, who joined as a Vice President, and Franklin Garstin, who has joined as an Associate.\n<\/p>\n

\nKevin was previously the Director of Business Development for Southern Orthodontic Partners, a Shore Capital portfolio company, where he played an active role in growing the company from two doctors in one state to over 50 doctors across eight states. Prior to this, Kevin was an Associate at Pharos Capital Group, a healthcare-focused private equity firm, and started his career as an investment banking analyst with Stephens Inc.\n<\/p>\n

\nFranklin joined Heritage from Alvarez & Marsal, where he was a Senior Associate in Healthcare Transaction Advisory, and previously worked as an associate at Deloitte, where he focused on healthcare audit work.\n<\/p>\n

\n\u201cWe look forward to building upon the success of our strategic healthcare investment model and are pleased to welcome Kevin and Franklin as members of our growing team,\u201d said Graham Hunter, Partner at Heritage Group.\n<\/p>\n

\nAbout Heritage Group<\/b>\n<\/p>\n

\nHeritage Group is a Nashville, Tennessee based, healthcare-focused private equity firm with more than 35 years of experience financing and operating healthcare companies. Heritage has over $700 million of assets under management and seeks to make majority and minority investments in high-growth healthcare services and healthcare technology businesses that address the challenges of the U.S. healthcare system. The firm’s limited partners include some of the leading healthcare organizations in the nation, including large provider systems, payers, and healthcare service providers, which collectively operate over 600 hospitals and insure more than 45 million lives. For more information, visit www.heritagegroupusa.com<\/a>.\n<\/p>\n

Contacts<\/b> <\/p>\n

\nFlorence Chassaignac
\n
florence@heritagegroupusa.com<\/a>
615-263-7832\n<\/p>\n<\/div>\n","protected":false},"excerpt":{"rendered":"

NASHVILLE, Tenn.–(BUSINESS WIRE)–Heritage Group, a healthcare-focused private equity firm, is pleased to announce the promotion of Matt Tome to Vice President, as well as the addition of two new members to the investment team, Kevin Ryan, Vice President and Franklin Garstin, Associate. Matt Tome joined Heritage in 2019 as an Associate. Prior to joining Heritage, … [Read more…]<\/a><\/span><\/p>\n","protected":false},"author":4,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[13],"tags":[],"class_list":{"0":"entry","1":"post","2":"publish","3":"author-business","4":"post-53241","6":"format-standard","7":"category-industry"},"yoast_head":"\nHeritage Group Expands Investment Team and Announces Vice President Promotion - Pharma Trend<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/pharma-trend.com\/en\/heritage-group-expands-investment-team-and-announces-vice-president-promotion\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Heritage Group Expands Investment Team and Announces Vice President Promotion - Pharma Trend\" \/>\n<meta property=\"og:description\" content=\"NASHVILLE, Tenn.–(BUSINESS WIRE)–Heritage Group, a healthcare-focused private equity firm, is pleased to announce the promotion of Matt Tome to Vice President, as well as the addition of two new members to the investment team, Kevin Ryan, Vice President and Franklin Garstin, Associate. Matt Tome joined Heritage in 2019 as an Associate. Prior to joining Heritage, ... [Read more...]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/pharma-trend.com\/en\/heritage-group-expands-investment-team-and-announces-vice-president-promotion\/\" \/>\n<meta property=\"og:site_name\" content=\"Pharma Trend\" \/>\n<meta property=\"article:published_time\" content=\"2023-01-24T16:02:25+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/mms.businesswire.com\/media\/20230124005171\/en\/1693068\/21\/HG_logo.jpg\" \/>\n<meta name=\"author\" content=\"Business Wire\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Business Wire\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/heritage-group-expands-investment-team-and-announces-vice-president-promotion\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/heritage-group-expands-investment-team-and-announces-vice-president-promotion\\\/\"},\"author\":{\"name\":\"Business Wire\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/person\\\/02d41342c7a74fa7f0032bb35ef0bb24\"},\"headline\":\"Heritage Group Expands Investment Team and Announces Vice President Promotion\",\"datePublished\":\"2023-01-24T16:02:25+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/heritage-group-expands-investment-team-and-announces-vice-president-promotion\\\/\"},\"wordCount\":486,\"publisher\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/heritage-group-expands-investment-team-and-announces-vice-president-promotion\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20230124005171\\\/en\\\/1693068\\\/21\\\/HG_logo.jpg\",\"articleSection\":[\"Industry\"],\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/heritage-group-expands-investment-team-and-announces-vice-president-promotion\\\/\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/heritage-group-expands-investment-team-and-announces-vice-president-promotion\\\/\",\"name\":\"Heritage Group Expands Investment Team and Announces Vice President Promotion - Pharma Trend\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/heritage-group-expands-investment-team-and-announces-vice-president-promotion\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/heritage-group-expands-investment-team-and-announces-vice-president-promotion\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20230124005171\\\/en\\\/1693068\\\/21\\\/HG_logo.jpg\",\"datePublished\":\"2023-01-24T16:02:25+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/heritage-group-expands-investment-team-and-announces-vice-president-promotion\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/pharma-trend.com\\\/en\\\/heritage-group-expands-investment-team-and-announces-vice-president-promotion\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/heritage-group-expands-investment-team-and-announces-vice-president-promotion\\\/#primaryimage\",\"url\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20230124005171\\\/en\\\/1693068\\\/21\\\/HG_logo.jpg\",\"contentUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20230124005171\\\/en\\\/1693068\\\/21\\\/HG_logo.jpg\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/heritage-group-expands-investment-team-and-announces-vice-president-promotion\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Startseite\",\"item\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Heritage Group Expands Investment Team and Announces Vice President Promotion\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#website\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\",\"name\":\"Pharma Trend\",\"description\":\"\",\"publisher\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\",\"name\":\"Pharma Trend\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"\",\"contentUrl\":\"\",\"caption\":\"Pharma Trend\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\"}},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/person\\\/02d41342c7a74fa7f0032bb35ef0bb24\",\"name\":\"Business Wire\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Heritage Group Expands Investment Team and Announces Vice President Promotion - Pharma Trend","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/pharma-trend.com\/en\/heritage-group-expands-investment-team-and-announces-vice-president-promotion\/","og_locale":"en_US","og_type":"article","og_title":"Heritage Group Expands Investment Team and Announces Vice President Promotion - Pharma Trend","og_description":"NASHVILLE, Tenn.–(BUSINESS WIRE)–Heritage Group, a healthcare-focused private equity firm, is pleased to announce the promotion of Matt Tome to Vice President, as well as the addition of two new members to the investment team, Kevin Ryan, Vice President and Franklin Garstin, Associate. Matt Tome joined Heritage in 2019 as an Associate. Prior to joining Heritage, ... [Read more...]","og_url":"https:\/\/pharma-trend.com\/en\/heritage-group-expands-investment-team-and-announces-vice-president-promotion\/","og_site_name":"Pharma Trend","article_published_time":"2023-01-24T16:02:25+00:00","og_image":[{"url":"https:\/\/mms.businesswire.com\/media\/20230124005171\/en\/1693068\/21\/HG_logo.jpg","type":"","width":"","height":""}],"author":"Business Wire","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Business Wire","Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/pharma-trend.com\/en\/heritage-group-expands-investment-team-and-announces-vice-president-promotion\/#article","isPartOf":{"@id":"https:\/\/pharma-trend.com\/en\/heritage-group-expands-investment-team-and-announces-vice-president-promotion\/"},"author":{"name":"Business Wire","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/person\/02d41342c7a74fa7f0032bb35ef0bb24"},"headline":"Heritage Group Expands Investment Team and Announces Vice President Promotion","datePublished":"2023-01-24T16:02:25+00:00","mainEntityOfPage":{"@id":"https:\/\/pharma-trend.com\/en\/heritage-group-expands-investment-team-and-announces-vice-president-promotion\/"},"wordCount":486,"publisher":{"@id":"https:\/\/pharma-trend.com\/en\/#organization"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/heritage-group-expands-investment-team-and-announces-vice-president-promotion\/#primaryimage"},"thumbnailUrl":"https:\/\/mms.businesswire.com\/media\/20230124005171\/en\/1693068\/21\/HG_logo.jpg","articleSection":["Industry"],"inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/pharma-trend.com\/en\/heritage-group-expands-investment-team-and-announces-vice-president-promotion\/","url":"https:\/\/pharma-trend.com\/en\/heritage-group-expands-investment-team-and-announces-vice-president-promotion\/","name":"Heritage Group Expands Investment Team and Announces Vice President Promotion - Pharma Trend","isPartOf":{"@id":"https:\/\/pharma-trend.com\/en\/#website"},"primaryImageOfPage":{"@id":"https:\/\/pharma-trend.com\/en\/heritage-group-expands-investment-team-and-announces-vice-president-promotion\/#primaryimage"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/heritage-group-expands-investment-team-and-announces-vice-president-promotion\/#primaryimage"},"thumbnailUrl":"https:\/\/mms.businesswire.com\/media\/20230124005171\/en\/1693068\/21\/HG_logo.jpg","datePublished":"2023-01-24T16:02:25+00:00","breadcrumb":{"@id":"https:\/\/pharma-trend.com\/en\/heritage-group-expands-investment-team-and-announces-vice-president-promotion\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/pharma-trend.com\/en\/heritage-group-expands-investment-team-and-announces-vice-president-promotion\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/pharma-trend.com\/en\/heritage-group-expands-investment-team-and-announces-vice-president-promotion\/#primaryimage","url":"https:\/\/mms.businesswire.com\/media\/20230124005171\/en\/1693068\/21\/HG_logo.jpg","contentUrl":"https:\/\/mms.businesswire.com\/media\/20230124005171\/en\/1693068\/21\/HG_logo.jpg"},{"@type":"BreadcrumbList","@id":"https:\/\/pharma-trend.com\/en\/heritage-group-expands-investment-team-and-announces-vice-president-promotion\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Startseite","item":"https:\/\/pharma-trend.com\/en\/"},{"@type":"ListItem","position":2,"name":"Heritage Group Expands Investment Team and Announces Vice President Promotion"}]},{"@type":"WebSite","@id":"https:\/\/pharma-trend.com\/en\/#website","url":"https:\/\/pharma-trend.com\/en\/","name":"Pharma Trend","description":"","publisher":{"@id":"https:\/\/pharma-trend.com\/en\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/pharma-trend.com\/en\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/pharma-trend.com\/en\/#organization","name":"Pharma Trend","url":"https:\/\/pharma-trend.com\/en\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/logo\/image\/","url":"","contentUrl":"","caption":"Pharma Trend"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/logo\/image\/"}},{"@type":"Person","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/person\/02d41342c7a74fa7f0032bb35ef0bb24","name":"Business Wire"}]}},"_links":{"self":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts\/53241","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/users\/4"}],"replies":[{"embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/comments?post=53241"}],"version-history":[{"count":0,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts\/53241\/revisions"}],"wp:attachment":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/media?parent=53241"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/categories?post=53241"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/tags?post=53241"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}